Correlation Between Merck and Entero Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Merck and Entero Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Entero Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Entero Therapeutics,, you can compare the effects of market volatilities on Merck and Entero Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Entero Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Entero Therapeutics,.
Diversification Opportunities for Merck and Entero Therapeutics,
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Merck and Entero is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Entero Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entero Therapeutics, and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Entero Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entero Therapeutics, has no effect on the direction of Merck i.e., Merck and Entero Therapeutics, go up and down completely randomly.
Pair Corralation between Merck and Entero Therapeutics,
Considering the 90-day investment horizon Merck Company is expected to generate 0.19 times more return on investment than Entero Therapeutics,. However, Merck Company is 5.39 times less risky than Entero Therapeutics,. It trades about -0.22 of its potential returns per unit of risk. Entero Therapeutics, is currently generating about -0.22 per unit of risk. If you would invest 10,664 in Merck Company on August 23, 2024 and sell it today you would lose (678.00) from holding Merck Company or give up 6.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Merck Company vs. Entero Therapeutics,
Performance |
| Timeline |
| Merck Company |
| Entero Therapeutics, |
Merck and Entero Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merck and Entero Therapeutics,
The main advantage of trading using opposite Merck and Entero Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Entero Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entero Therapeutics, will offset losses from the drop in Entero Therapeutics,'s long position.| Merck vs. Johnson Johnson | Merck vs. Small Cap Core | Merck vs. Freedom Holding Corp | Merck vs. Gfl Environmental Holdings |
| Entero Therapeutics, vs. ZyVersa Therapeutics | Entero Therapeutics, vs. Sonnet Biotherapeutics Holdings | Entero Therapeutics, vs. Zura Bio Limited | Entero Therapeutics, vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |